Page 31 - Read Online

Page 8 of 10 Xiao et al. Microbiome Res Rep 2024;3:7 https://dx.doi.org/10.20517/mrr.2023.48

REFERENCES
1. Fan Y, Pedersen O. Gut microbiota in human metabolic health and disease. Nat Rev Microbiol 2021;19:55-71. DOI PubMed
2. Lee JY, Tsolis RM, Bäumler AJ. The microbiome and gut homeostasis. Science 2022;377:eabp9960. DOI PubMed
3. Sencio V, Machado MG, Trottein F. The lung-gut axis during viral respiratory infections: the impact of gut dysbiosis on secondary
disease outcomes. Mucosal Immunol 2021;14:296-304. DOI PubMed
4. Arpaia N, Campbell C, Fan X, et al. Metabolites produced by commensal bacteria promote peripheral regulatory T-cell generation.
Nature 2013;504:451-5. DOI PubMed
5. He F, Deng Y, Li W. Coronavirus disease 2019: what we know? J Med Virol 2020;92:719-25. DOI PubMed
6. Zuo T, Zhang F, Lui GCY, et al. Alterations in gut microbiota of patients with COVID-19 during time of hospitalization.
Gastroenterology 2020;159:944-55.e8. DOI PubMed
7. Gomaa EZ. Human gut microbiota/microbiome in health and diseases: a review. Antonie Van Leeuwenhoek 2020;113:2019-40. DOI
PubMed
8. Wu Y, Cheng X, Jiang G, et al. Altered oral and gut microbiota and its association with SARS-CoV-2 viral load in COVID-19 patients
during hospitalization. NPJ Biofilms Microbiomes 2021;7:61. DOI PubMed
9. He F, Zhang T, Xue K, et al. Fecal multi-omics analysis reveals diverse molecular alterations of gut ecosystem in COVID-19 patients.
Anal Chim Acta 2021;1180:338881. DOI PubMed
10. Zuo T, Zhan H, Zhang F, et al. Alterations in fecal fungal microbiome of patients with COVID-19 during time of hospitalization until
discharge. Gastroenterology 2020;159:1302-10.e5. DOI PubMed
11. Shen Y, Yu F, Zhang D, et al. Dynamic alterations in the respiratory tract microbiota of patients with COVID-19 and its association
with microbiota in the gut. Adv Sci 2022;9:e2200956. DOI PubMed
12. Gu S, Chen Y, Wu Z, et al. Alterations of the gut microbiota in patients with coronavirus disease 2019 or H1N1 influenza. Clin Infect
Dis 2020;71:2669-78. DOI PubMed
13. Zhang F, Wan Y, Zuo T, et al. Prolonged impairment of short-chain fatty acid and L-isoleucine biosynthesis in gut microbiome in
patients with COVID-19. Gastroenterology 2022;162:548-61.e4. DOI PubMed
14. Lv W, He J, Shao J, Chen Y, Xia L, Zhang L. Causal relationships between short-chain fatty acids and L-isoleucine biosynthesis and
susceptibility and severity of COVID-19: evidence from Mendelian randomization. J Infect 2023;87:e16-8. DOI PubMed
15. Lv L, Jiang H, Chen Y, et al. The faecal metabolome in COVID-19 patients is altered and associated with clinical features and gut
microbes. Anal Chim Acta 2021;1152:338267. DOI PubMed
16. Yelin D, Margalit I, Yahav D, Runold M, Bruchfeld J. Long COVID-19-it’s not over until? Clin Microbiol Infect 2021;27:506-8. DOI
PubMed
17. Vestad B, Ueland T, Lerum TV, et al. Respiratory dysfunction three months after severe COVID-19 is associated with gut microbiota
alterations. J Intern Med 2022;291:801-12. DOI PubMed
18. Cui GY, Rao BC, Zeng ZH, et al. Characterization of oral and gut microbiome and plasma metabolomics in COVID-19 patients after
1-year follow-up. Mil Med Res 2022;9:32. DOI PubMed
19. Su Q, Lau RI, Liu Q, Chan FKL, Ng SC. Post-acute COVID-19 syndrome and gut dysbiosis linger beyond 1 year after SARS-CoV-2
clearance. Gut 2023;72:1230-2. DOI PubMed
20. Dumas A, Bernard L, Poquet Y, Lugo-Villarino G, Neyrolles O. The role of the lung microbiota and the gut-lung axis in respiratory
infectious diseases. Cell Microbiol 2018;20:e12966. DOI PubMed
21. Wang J, Li F, Wei H, Lian ZX, Sun R, Tian Z. Respiratory influenza virus infection induces intestinal immune injury via microbiota-
mediated Th17 cell-dependent inflammation. J Exp Med 2014;211:2397-410. DOI PubMed
22. Groves HT, Higham SL, Moffatt MF, Cox MJ, Tregoning JS. Respiratory viral infection alters the gut microbiota by inducing
inappetence. mBio 2020;11:e03236-19. DOI
23. Merad M, Martin JC. Pathological inflammation in patients with COVID-19: a key role for monocytes and macrophages. Nat Rev
Immunol 2020;20:355-62. DOI PubMed
24. Cerf-Bensussan N, Gaboriau-Routhiau V. The immune system and the gut microbiota: friends or foes? Nat Rev Immunol 2010;10:735-
44. DOI PubMed
25. Liang W, Feng Z, Rao S, et al. Diarrhoea may be underestimated: a missing link in 2019 novel coronavirus. Gut 2020;69:1141-3. DOI
PubMed
26. Qi F, Qian S, Zhang S, Zhang Z. Single cell RNA sequencing of 13 human tissues identify cell types and receptors of human
coronaviruses. Biochem Biophys Res Commun 2020;526:135-40. DOI PubMed
27. Hoffmann M, Kleine-Weber H, Schroeder S, et al. SARS-CoV-2 cell entry depends on ACE2 and TMPRSS2 and is blocked by a
clinically proven protease inhibitor. Cell 2020;181:271-80.e8. DOI PubMed
28. Walls AC, Park YJ, Tortorici MA, Wall A, McGuire AT, Veesler D. Structure, function, and antigenicity of the SARS-CoV-2 spike
glycoprotein. Cell 2020;183:1735. DOI PubMed
29. Lin L, Jiang X, Zhang Z, et al. Gastrointestinal symptoms of 95 cases with SARS-CoV-2 infection. Gut 2020;69:997-1001. DOI
PubMed
30. Jiang X, Luo M, Zou Z, Wang X, Chen C, Qiu J. Asymptomatic SARS-CoV-2 infected case with viral detection positive in stool but
negative in nasopharyngeal samples lasts for 42 days. J Med Virol 2020;92:1807-9. DOI PubMed